{"schema_version":"1","generated_at":"2026-11-08T17:18:11.849Z","data_as_of":null,"url":"https://www.findmykol.com/kol/nicole-carreau","json_url":"https://www.findmykol.com/kol/nicole-carreau/profile.json","record_kind":"basic","profile_kind":"clinical","person":{"slug":"nicole-carreau","name":"Nicole Carreau","credential":"MD","specialty":"Hematology / Oncology","specialty_raw":"Hematology & Oncology","therapeutic_area":"Oncology","therapeutic_areas":["Oncology"],"city":"Norwalk","state":"CT","region":{"label":"Northeast","url":"https://www.findmykol.com/region/northeast"}},"identifiers":{"npi":"1104168962","orcid":"0000-0001-7782-8090","openalex":"A5067043341"},"summary":"Nicole Carreau is an Oncology physician. OpenAlex indexes 18 publications with 1,153 citations (h-index 12).","overview":null,"focus":{"indications":[],"research_topics":["Oncology"]},"scholarship":{"works_count":18,"cited_by_count":1153,"h_index":12,"latest_activity_year":2025,"source":"works"},"payments":{"company_count":29,"program_years":{"first":2021,"last":null},"rows_total":48,"shown":3,"withheld":45,"rows":[{"payer":"PFIZER INC.","program_year":2025,"amount_usd":40.51,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1104168962"},{"payer":"Novartis Pharmaceuticals Corporation","program_year":2025,"amount_usd":39.59,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1104168962"},{"payer":"ARRAY BIOPHARMA INC","program_year":2025,"amount_usd":35.99,"payment_count":2,"source_url":"https://openpaymentsdata.cms.gov/search?query=1104168962"}],"record_url":"https://openpaymentsdata.cms.gov/search?query=1104168962","source":"payments"},"publications":{"total":18,"shown":5,"withheld":13,"matched_by":"OpenAlex author record","recent":[{"title":"Checkpoint Blockade Treatment May Sensitize Hodgkin Lymphoma to Subsequent Therapy","year":2020,"journal":"The Oncologist","source_url":"https://doi.org/10.1634/theoncologist.2020-0167","status":"verified"},{"title":"Checkpoint blockade treatment sensitises relapsed/refractory non‐Hodgkin lymphoma to subsequent therapy","year":2020,"journal":"British Journal of Haematology","source_url":"https://doi.org/10.1111/bjh.16756","status":"verified"},{"title":"Impact of Treatment Beyond Progression with Immune Checkpoint Blockade in Hodgkin Lymphoma","year":2020,"journal":"The Oncologist","source_url":"https://doi.org/10.1634/theoncologist.2020-0040","status":"verified"},{"title":"Revolutionizing treatment of advanced melanoma with immunotherapy","year":2019,"journal":"Surgical Oncology","source_url":"https://doi.org/10.1016/j.suronc.2019.01.002","status":"verified"},{"title":"Immune targeting of the microenvironment in classical Hodgkin’s lymphoma: insights for the hematologist","year":2019,"journal":"Therapeutic Advances in Hematology","source_url":"https://doi.org/10.1177/2040620719846451","status":"verified"}],"source":"works"},"contact":{"address_1":"34 MAPLE ST","city":"Norwalk","state":"CT","zip":"068503815","phone":"203-845-4811","source_url":"https://npiregistry.cms.hhs.gov/provider-view/1104168962","source":"identity"},"similar":[{"name":"Carl June","slug":"carl-june","institution":"University of Pennsylvania","specialty":"Medical Oncology","url":"https://www.findmykol.com/kol/carl-june","json_url":"https://www.findmykol.com/kol/carl-june/profile.json"},{"name":"Rainer Storb","slug":"rainer-storb","institution":"University of Washington","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/rainer-storb","json_url":"https://www.findmykol.com/kol/rainer-storb/profile.json"},{"name":"Christina Fitzmaurice","slug":"christina-fitzmaurice","specialty":"Hematology / Oncology","url":"https://www.findmykol.com/kol/christina-fitzmaurice","json_url":"https://www.findmykol.com/kol/christina-fitzmaurice/profile.json"},{"name":"Beth Karlan","slug":"beth-karlan","institution":"University of California, Los Angeles","specialty":"Gynecologic Oncology","url":"https://www.findmykol.com/kol/beth-karlan","json_url":"https://www.findmykol.com/kol/beth-karlan/profile.json"}],"coverage":{"note":"A basic directory record. Sections absent here were not yet checked for this person, so absence means not yet looked, never none found.","not_yet_checked":["funding","congress","network","presence","recognition"]},"not_included":{"note":"This document is the public layer: neutral facts cited to their source. Judgments (influence tier, archetype, trajectory commentary) and the itemized rows past each section's public teaser are account features and are not served here or to crawlers.","withheld_rows":{"payments":45,"publications":13}},"sources":{"orcid":{"name":"ORCID","url":"https://orcid.org","provides":"The verified researcher identity that anchors authorship"},"identity":{"name":"NPPES (CMS)","url":"https://npiregistry.cms.hhs.gov","provides":"Identity, specialty and practice location for every U.S. clinician","coverage":"Practice location (not mailing) from the NPPES record","record_last_updated":"2020-02-13","provider_certified":"2020-02-13","collected_at":"2026-11-06T00:00:00.000Z"},"works":{"name":"OpenAlex","url":"https://openalex.org","provides":"Citations, h-index, research topics, most-cited works and congress abstracts"},"payments":{"name":"CMS Open Payments","url":"https://openpaymentsdata.cms.gov","provides":"Industry payments reported to CMS, by company and program year","disclaimer":"Payments are publicly reported to CMS. Their existence does not imply wrongdoing; CMS does not interpret these data.","coverage":"Program years 2021 onward"}},"methodology_url":"https://www.findmykol.com/about#methodology"}